| ACE2 | Angiotensin converting enzyme 2 |
| AIDS | Acquired immune deficiency syndrome |
| AD | Alzheimer’s disease |
| AMOP | Adhesion-associated domain in MUC4 and other proteins |
| BACE1 | β-site amyloid precursor protein cleaving enzyme 1 |
| CFD | Computational fluid dynamic |
| COVID-19 | Coronavirus disease 2019 |
| DLPC | Dilauroylphosphatidylcholine |
| DMBT1 | Deleted in malignant brain tumor 1 |
| DPPC | Dipalmitoyl phosphatidylcholine |
| EGF | Epidermal growth factor |
| FDA | Drug administration |
| GRAS | Generally regarded as safe |
| HA | Hemagglutinin |
| LL-37 | Cathelicidins |
| MERS | Middle east respiratory syndrome coronavirus |
| NA | Neuraminidase |
| NIDO | Nidogen-like domain |
| PC | Phosphatidylcholine |
| PD | Parkinson’s disease |
| PEG | Polyethylene glycol |
| PLA | Polylactic acid |
| PLGA | Poly(lactic-co-glycolic acid) |
| PLUC | Nasal epithelium clone |
| PTS | Proline, threonine, serine rich |
| PVA | Polyvinyl acetate |
| RSV | Respiratory syncytial virus |
| SARS-CoV | Severe acute respiratory syndrome corona virus |
| SEA | Sea urchin sperm protein |
| SP | Surfactant protein |
| TPGS | Tocopherol polyethylene glycol succinate |
| vWD | von Willebrand factor D |